Skip to main content

Advertisement

ADVERTISEMENT

Conference Coverage

psoriasis
Conference Coverage
04/26/2023
Jessica Garlewicz, Digital Managing Editor
Christopher T. Ritchlin, MD, MPH, provided the keynote kickoff for the Interdisciplinary Autoimmune Summit virtual meeting April 26 by addressing advances in the treatment of immune-mediated inflammatory diseases.
Christopher T. Ritchlin, MD, MPH, provided the keynote kickoff for the Interdisciplinary Autoimmune Summit virtual meeting April 26 by addressing advances in the treatment of immune-mediated inflammatory diseases.
Christopher T. Ritchlin, MD,...
04/26/2023
The Dermatologist
Joel Gelfand
Conference Coverage
04/26/2023
Being more aggressive in managing traditional cardiovascular risk factors among patients with more severe psoriasis requires a team-based approach involving the dermatologist, cardiologist, and primary care providers.
Being more aggressive in managing traditional cardiovascular risk factors among patients with more severe psoriasis requires a team-based approach involving the dermatologist, cardiologist, and primary care providers.
Being more aggressive in...
04/26/2023
Autoimmune
Peter Lio
Conference Coverage
04/26/2023
Riya Gandhi, MA, Associate Editor
On the first day of the 2023 Interdisciplinary Autoimmune Summit, Peter Lio, MD, FAAD, presented his session, “JAK Inhibitor Safety in the Treatment of Atopic Dermatitis (AD): Evaluating the Long-Term Data.”
On the first day of the 2023 Interdisciplinary Autoimmune Summit, Peter Lio, MD, FAAD, presented his session, “JAK Inhibitor Safety in the Treatment of Atopic Dermatitis (AD): Evaluating the Long-Term Data.”
On the first day of the 2023...
04/26/2023
The Dermatologist

Advertisement

Joel Gelfand, MD
Conference Coverage
04/26/2023
Coleen Stern, MA, Senior Managing Editor
Joel M. Gelfand, MD, MSCE, and Joseph R. Merola, MD, MMSc, explored trends in dermatology practice organization and the impact of drug development, research priorities, and emerging technology on clinical practice.
Joel M. Gelfand, MD, MSCE, and Joseph R. Merola, MD, MMSc, explored trends in dermatology practice organization and the impact of drug development, research priorities, and emerging technology on clinical practice.
Joel M. Gelfand, MD, MSCE, and...
04/26/2023
The Dermatologist
Leonard Calabrese, DO
Conference Coverage
04/26/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Leonard Calabrese, DO, discussed the risks and complications of SARS-CoV-2 among immunocompromised patients at the Interdisciplinary Autoimmune Summit virtual session.
Leonard Calabrese, DO, discussed the risks and complications of SARS-CoV-2 among immunocompromised patients at the Interdisciplinary Autoimmune Summit virtual session.
Leonard Calabrese, DO, discussed...
04/26/2023
Autoimmune
skin of color prurigo nodularis
Conference Coverage
04/26/2023
Jessica Garlewicz, Digital Managing Editor
Shawn Kwatra, MD, described the clinical features, pathophysiology, and burden of disease in prurigo nodularis.
Shawn Kwatra, MD, described the clinical features, pathophysiology, and burden of disease in prurigo nodularis.
Shawn Kwatra, MD, described the...
04/26/2023
The Dermatologist

Advertisement

Stephen Hanauer
Conference Coverage
04/26/2023
Dr Hanauer emphasizes how a number of potential human models can be used to more accurately evaluate the pathogenesis of inflammatory bowel disease by studying human patients rather than mice.
Dr Hanauer emphasizes how a number of potential human models can be used to more accurately evaluate the pathogenesis of inflammatory bowel disease by studying human patients rather than mice.
Dr Hanauer emphasizes how a...
04/26/2023
Autoimmune
woman writing on computer
Conference Coverage
04/11/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Data from the Psoriasis Epidemiology Screening Tool survey found that evaluation by a rheumatologist was beneficial in patient-driven psoriatic arthritis screening.
Data from the Psoriasis Epidemiology Screening Tool survey found that evaluation by a rheumatologist was beneficial in patient-driven psoriatic arthritis screening.
Data from the Psoriasis...
04/11/2023
Rheumatology & Arthritis
Saakshi Khattri, MD
Conference Coverage
03/07/2023

Rebecca Mashaw, Managing Editor

Rebecca Mashaw, Managing Editor ...
Results from the KEEPsAKE 1 and 2 trials demonstrated the efficacy of risankizumab in achieving and maintaining resolution of dactylitis and enthesitis among patients with psoriatic arthritis.
Results from the KEEPsAKE 1 and 2 trials demonstrated the efficacy of risankizumab in achieving and maintaining resolution of dactylitis and enthesitis among patients with psoriatic arthritis.
Results from the KEEPsAKE 1 and...
03/07/2023
Rheumatology & Arthritis

Advertisement

Laura Coates
Conference Coverage
02/22/2023
Dr Coates presented a poster at ACR Convergence examining the efficacy of upadacitinib vs adalimumab in treating psoriatic arthritis, using the RAPID3 tool to assess disease activity.
Dr Coates presented a poster at ACR Convergence examining the efficacy of upadacitinib vs adalimumab in treating psoriatic arthritis, using the RAPID3 tool to assess disease activity.
Dr Coates presented a poster at...
02/22/2023
Rheumatology & Arthritis

Advertisement